Swiss Life Asset Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $119M | Sell |
537,743
-104,287
| -16% | -$28.8M | 0.49% | 37 |
|
|
2026
Q1 | $175M | Buy |
642,030
+104,247
| +19% | +$31M | 0.86% | 16 |
|
|
2025
Q4 | $147M | Sell |
537,783
-184,900
| -26% | -$50.2M | 0.75% | 17 |
|
|
2025
Q3 | $195M | Sell |
722,683
-11,648
| -2% | -$3.17M | 1.02% | 15 |
|
|
2025
Q2 | $202M | Buy |
734,331
+6,136
| +0.8% | +$1.67M | 1.19% | 13 |
|
|
2025
Q1 | $193M | Buy |
728,195
+7,927
| +1% | +$1.96M | 1.4% | 13 |
|
|
2024
Q4 | $167M | Buy |
720,268
+621,072
| +626% | +$143M | 1.23% | 13 |
|
|
2024
Q3 | $21.9M | Buy |
99,196
+565
| +0.6% | +$117K | 0.25% | 89 |
|
|
2024
Q2 | $19.4M | Buy |
98,631
+2,948
| +3% | +$609K | 0.23% | 97 |
|
|
2024
Q1 | $20.6M | Buy |
95,683
+54,294
| +131% | +$11.4M | 0.29% | 81 |
|
|
2023
Q4 | $8.73M | Buy |
41,389
+690
| +2% | +$147K | 0.1% | 221 |
|
|
2023
Q3 | $8.15M | Buy |
40,699
+9,306
| +30% | +$1.85M | 0.13% | 189 |
|
|
2023
Q2 | $5.82M | Sell |
31,393
-3,845
| -11% | -$711K | 0.09% | 272 |
|
|
2023
Q1 | $6.75M | Sell |
35,238
-14,577
| -29% | -$2.64M | 0.1% | 254 |
|
|
2022
Q4 | $8.4M | Sell |
49,815
-8,579
| -15% | -$1.49M | 0.14% | 188 |
|
|
2022
Q3 | $10.3M | Sell |
58,394
-7,677
| -12% | -$1.52M | 0.18% | 145 |
|
|
2022
Q2 | $13.6M | Sell |
66,071
-3,000
| -4% | -$636K | 0.22% | 102 |
|
|
2022
Q1 | $16.4M | Sell |
69,071
-417
| -0.6% | -$97.9K | 0.23% | 104 |
|
|
2021
Q4 | $15.9M | Sell |
69,488
-13,195
| -16% | -$2.9M | 0.21% | 110 |
|
|
2021
Q3 | $16M | Sell |
82,683
-1,213
| -1% | -$246K | 0.22% | 106 |
|
|
2021
Q2 | $14.8M | Buy |
83,896
+8,822
| +12% | +$1.86M | 0.15% | 125 |
|
|
2021
Q1 | $15.3M | Buy |
75,074
+6,290
| +9% | +$1.24M | 0.22% | 106 |
|
|
2020
Q4 | $12.5M | Buy |
68,784
+33,230
| +93% | +$5.65M | 0.18% | 120 |
|
|
2020
Q3 | $5.93M | Buy |
35,554
+2,602
| +8% | +$438K | 0.09% | 175 |
|
|
2020
Q2 | $5.36M | Sell |
32,952
-14,082
| -30% | -$2.52M | 0.09% | 177 |
|
|
2020
Q1 | $8.14M | Buy |
47,034
+6,697
| +17% | +$1.33M | 0.15% | 125 |
|
|
2019
Q4 | $8.11M | Sell |
40,337
-12,156
| -23% | -$2.49M | 0.15% | 124 |
|
|
2019
Q3 | $11.1M | Sell |
52,493
-4,001
| -7% | -$836K | 0.14% | 119 |
|
|
2019
Q2 | $10.9M | Buy |
56,494
+18,375
| +48% | +$3.39M | 0.13% | 125 |
|
|
2019
Q1 | $6.27M | Sell |
38,119
-67,596
| -64% | -$12M | 0.08% | 160 |
|
|
2018
Q4 | $19.9M | Sell |
105,715
-40,452
| -28% | -$7.47M | 0.4% | 80 |
|
|
2018
Q3 | $24.9M | Buy |
146,167
+29,286
| +25% | +$4.93M | 0.33% | 84 |
|
|
2018
Q2 | $19.2M | Buy |
116,881
+16,210
| +16% | +$2.65M | 0.29% | 95 |
|
|
2018
Q1 | $16.3M | Buy |
100,671
+61,809
| +159% | +$9.84M | 0.28% | 103 |
|
|
2017
Q4 | $5.68M | Sell |
38,862
-7,372
| -16% | -$1.05M | 0.13% | 112 |
|
|
2017
Q3 | $6.26M | Buy |
+46,234
| New | +$5.84M | 0.17% | 109 |
|
|
2017
Q2 | – | Sell |
-3,507
| Closed | -$417K | – | 460 |
|
|
2017
Q1 | $417K | Sell |
3,507
-2,475
| -41% | -$298K | 0.01% | 399 |
|
|
2016
Q4 | $690K | Hold |
5,982
| – | – | 0.02% | 312 |
|
|
2016
Q3 | $625K | Sell |
5,982
-164
| -3% | -$17.1K | 0.02% | 313 |
|
|
2016
Q2 | $597K | Hold |
6,146
| – | – | 0.02% | 217 |
|
|
2016
Q1 | $590K | Buy |
+6,146
| New | +$559K | 0.02% | 243 |
|
|
2015
Q4 | – | Sell |
-3,961
| Closed | -$367K | – | 322 |
|
|
2015
Q3 | $367K | Sell |
3,961
-3,252
| -45% | -$309K | 0.02% | 243 |
|
|
2015
Q2 | $671K | Sell |
7,213
-8,037
| -53% | -$750K | 0.02% | 167 |
|
|
2015
Q1 | $1.44M | Buy |
+15,250
| New | +$1.41M | 0.06% | 136 |
|
Other funds holding CME
AI
Swiss Life Asset Management's CME Position: Q2 2026 in Review
Swiss Life Asset Management reduced its CME Group (CME) stake by 16% in Q2 2026, selling an estimated $28.8M and leaving 537,743 shares worth $119M. The position accounts for 0.49% of the portfolio, ranked #37.
Swiss Life Asset Management first reported a position in CME in Q1 2015 and has held it in 44 quarters since. The position peaked at $202M in Q2 2025. 1,169 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Swiss Life Asset Management held 537,743 shares of CME Group worth $119M as of Q2 2026.
- Swiss Life Asset Management sold 104,287 CME Group shares in Q2 2026, an estimated $28.8M.
- CME Group made up 0.49% of Swiss Life Asset Management's portfolio in Q2 2026, its #37 holding.
- Swiss Life Asset Management first reported a position in CME Group in Q1 2015 and has held it in 44 quarters since.
- Swiss Life Asset Management's CME Group position peaked at $202M in Q2 2025.
- 1,169 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.